Ina Møller
Publications
2018
-
Twohig, Daniel;
Rodriguez-Vieitez, Elena;
Sando, Sigrid Botne;
Berge, Guro;
Lauridsen, Camilla;
Møller, Ina.
(2018)
The relevance of cerebrospinal fluid α-synuclein levels to sporadic and familial Alzheimer's disease.
Acta neuropathologica communications
Academic article
-
Patra, Kalicharan;
Soosaipillai, Antoninus;
Sando, Sigrid Botne;
Lauridsen, Camilla;
Berge, Guro;
Møller, Ina.
(2018)
Assessment of kallikrein 6 as a cross-sectional and longitudinal biomarker for Alzheimer's disease.
Alzheimer's Research & Therapy
Academic article
2017
-
Lauridsen, Camilla;
Sando, Sigrid Botne;
Møller, Ina;
Berge, Guro;
Pomary, Precious Kwadzo;
Grøntvedt, Gøril Rolfseng.
(2017)
Cerebrospinal fluid Aβ43 is reduced in early-onset compared to late-onset Alzheimer's disease, but has similar diagnostic accuracy to Aβ42.
Frontiers in Aging Neuroscience
Academic article
-
Almdahl, Ina;
Lauridsen, Camilla;
Selnes, Per;
Kalheim, Lisa Flem;
Coello, Christopher;
Gajdzik, Beata.
(2017)
Cerebrospinal fluid levels of amyloid beta 1-43 mirror 1-42 in relation to imaging biomarkers of Alzheimer's disease.
Frontiers in Aging Neuroscience
Academic article
2016
-
Berge, Guro;
Sando, Sigrid Botne;
Albrektsen, Grethe;
Lauridsen, Camilla;
Møller, Ina;
Grøntvedt, Gøril Rolfseng.
(2016)
Alpha-synuclein measured in cerebrospinal fluid from patients with Alzheimer's disease, mild cognitive impairment, or healthy controls: a two year follow-up study.
BMC Neurology
Academic article
-
Lauridsen, Camilla;
Sando, Sigrid Botne;
Shabnam, Adiba;
Møller, Ina;
Berge, Guro;
Grøntvedt, Gøril Rolfseng.
(2016)
Cerebrospinal Fluid Levels of Amyloid Beta 1-43 in Patients with Amnestic Mild Cognitive Impairment or Early Alzheimer's Disease: A 2-Year Follow-Up Study.
Frontiers in Aging Neuroscience
Academic article
2015
-
Berge, Guro;
Lauridsen, Camilla;
Sando, Sigrid Botne;
Holder, Daniel Joseph;
Møller, Ina;
Aasly, Jan.
(2015)
Effect of tween-20 on core biomarkers measured in cerebrospinal fluid from patients with Alzheimer's disease, mild cognitive impairment, or healthy control individuals.
Journal of Alzheimer's Disease
Academic article
Journal publications
-
Twohig, Daniel;
Rodriguez-Vieitez, Elena;
Sando, Sigrid Botne;
Berge, Guro;
Lauridsen, Camilla;
Møller, Ina.
(2018)
The relevance of cerebrospinal fluid α-synuclein levels to sporadic and familial Alzheimer's disease.
Acta neuropathologica communications
Academic article
-
Patra, Kalicharan;
Soosaipillai, Antoninus;
Sando, Sigrid Botne;
Lauridsen, Camilla;
Berge, Guro;
Møller, Ina.
(2018)
Assessment of kallikrein 6 as a cross-sectional and longitudinal biomarker for Alzheimer's disease.
Alzheimer's Research & Therapy
Academic article
-
Lauridsen, Camilla;
Sando, Sigrid Botne;
Møller, Ina;
Berge, Guro;
Pomary, Precious Kwadzo;
Grøntvedt, Gøril Rolfseng.
(2017)
Cerebrospinal fluid Aβ43 is reduced in early-onset compared to late-onset Alzheimer's disease, but has similar diagnostic accuracy to Aβ42.
Frontiers in Aging Neuroscience
Academic article
-
Almdahl, Ina;
Lauridsen, Camilla;
Selnes, Per;
Kalheim, Lisa Flem;
Coello, Christopher;
Gajdzik, Beata.
(2017)
Cerebrospinal fluid levels of amyloid beta 1-43 mirror 1-42 in relation to imaging biomarkers of Alzheimer's disease.
Frontiers in Aging Neuroscience
Academic article
-
Berge, Guro;
Sando, Sigrid Botne;
Albrektsen, Grethe;
Lauridsen, Camilla;
Møller, Ina;
Grøntvedt, Gøril Rolfseng.
(2016)
Alpha-synuclein measured in cerebrospinal fluid from patients with Alzheimer's disease, mild cognitive impairment, or healthy controls: a two year follow-up study.
BMC Neurology
Academic article
-
Lauridsen, Camilla;
Sando, Sigrid Botne;
Shabnam, Adiba;
Møller, Ina;
Berge, Guro;
Grøntvedt, Gøril Rolfseng.
(2016)
Cerebrospinal Fluid Levels of Amyloid Beta 1-43 in Patients with Amnestic Mild Cognitive Impairment or Early Alzheimer's Disease: A 2-Year Follow-Up Study.
Frontiers in Aging Neuroscience
Academic article
-
Berge, Guro;
Lauridsen, Camilla;
Sando, Sigrid Botne;
Holder, Daniel Joseph;
Møller, Ina;
Aasly, Jan.
(2015)
Effect of tween-20 on core biomarkers measured in cerebrospinal fluid from patients with Alzheimer's disease, mild cognitive impairment, or healthy control individuals.
Journal of Alzheimer's Disease
Academic article
Teaching
Courses
- HBIOT2060 - Biomedical laboratory science adapted for student exchange: Histopathology, transfusion medicine and quality assurance
- MH2002 - Interprofessional collaboration - Områdeemne innen studieområde medisin og helse: BBIOING, BRADIO, CPSYR, HSGAUB
- HBIOT2021 - Medical Laboratory Technology: Quantification Techniques
- MH2001 - Interprofessional collaboration - Områdeemne innen studieområde medisin og helse
- HBIOT2033 - Medical Laboratory Technology - Medical Biochemistry, Microbiology and Pathology
- HBIOT2025 - Medical laboratory technology: quality assesment, validation of methods and statistics
- HBIOT2024 - Medical Laboratory Technology - Histological- and Immunological Techniques and Cytology
- HBIOT2035 - Bachelor thesis in Biomedical Laboratory Science
- HBIO6001 - Supervisor Education for Practice Supervisors
Knowledge Transfer
2023
-
PosterMøller, Ina. (2023) Jakten på avvik. Kvalitetsrevisjon på timeplanen. NITO Kvalitetsarbeid i medisinske laboratorier og workshops , Oslo 2023-11-09 - 2023-11-10
2022
-
LectureMøller, Ina. (2022) Grunnleggende veiledningskompetanse. NITO Pasientnær analysering , Trondheim 2022-11-21 - 2022-11-22
2017
-
PosterLauridsen, Camilla; Sando, Sigrid Botne; Møller, Ina; Berge, Guro; Pomary, Precious Kwadzo; Grøntvedt, Gøril Rolfseng. (2017) Cerebrospinal fluid levels of Aβ43 are significantly decreased in patients with early-onset compared to late-onset Alzheimer’s disease. AD/PD The 13th International Conference on Alzheimer's and Parkinson's Diseases (ADPD) , Wien 2017-03-29 - 2017-04-02